Abstract: Aim of this study is to recognize the efficacy and safety of liraglutide on our patients with uncontrolled type 2 diabetes.
Method: it is uncontrolled prospective study where patients with type 2 diabetes despite high dose of insulin their glycosylated hemoglobin more than 8%. Total insulin doses, weight of the patients, fasting blood glucose and glycosylated hemoglobin were noted in the beginning and repeated after 3 and 6 months.
Results: liraglutide started on 150 patients and only 128 complete the study. The mean weight reduced from 107.3 to 99 and where the mean glycosylated hemoglobin reduced from 11.2 to 8.9 after 3 months and to 8.1 after 6 months.
Conclusion: liraglutide is safe and has good effects on weight reduction and diabetic controlled on our patients. It is similar to what have been published internationally.
Title: EFFICACY OF LIRAGLUTIDE ON TREATMENT OF TYPE 2 DIABETES MELLITUS
Author: Mohammed Abdulrahman Alshaikh, Khalid Mohammed Bahamdein, Ali Abdulelah Fadel, Waleed Khalid Eiban, Naif Saud Alsifri
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
